Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?

Editorial

Arjun V Balar et al. BJU Int. 2011 Sep.

. 2011 Sep;108(5):699.

doi: 10.1111/j.1464-410X.2010.10006.x. Epub 2010 Nov 24.

No abstract available

Comment in

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
Scosyrev E, Messing EM. Scosyrev E, et al. BJU Int. 2011 Sep;108(5):700. doi: 10.1111/j.1464-410X.2011.10582.x. BJU Int. 2011. PMID: 21854526 No abstract available.

Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
Scosyrev E, Ely BW, Messing EM, Speights VO, Grossman HB, Wood DP, de Vere White RW, Vogelzang NJ, Trump DL, Natale RB, Tangen CM, Crawford ED, Thompson IM. Scosyrev E, et al. BJU Int. 2011 Sep;108(5):693-9. doi: 10.1111/j.1464-410X.2010.09900.x. Epub 2010 Nov 24. BJU Int. 2011. PMID: 21105991 Free PMC article. Clinical Trial.